Ex-Takeda Exec Settles SEC Insider Trading Claims
By Max Stendahl · February 9, 2012, 3:07 PM EST
A former Takeda Pharmaceuticals International Inc. executive agreed Thursday to pay $136,000 to settle a U.S. Securities and Exchange Commission suit alleging he profited from insider trading before a major Takeda...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login